Daily Newsletter

28 September 2023

Daily Newsletter

28 September 2023

3D Systems and Klarity partner to expand distribution of VSPBolus

Radiotherapy clinics across Canada and the US can now access the 3D-printed solution.

RanjithKumar Dharma September 28 2023

3D Systems has announced a partnership with Klarity to expand the distribution of its VSPBolus solution, which was approved by the US Food and Drug Administration (FDA).

Klarity will add VSP Bolus to its patient-specific 3D-printed products, Klarity Prints, powered by 3D Systems.

Klarity Prints is a service-based line of 3D-printed radiotherapy accessories, including VSP Bolus, which does not need specialised hardware or software.

3D Systems Healthcare Solutions EVP Menno Ellis said: “Klarity has a strong reputation in the radiation oncology sector for delivering superior products and service.

“The company’s commitment to improving patient care through treatment personalisation aligns with 3D Systems’ market-leading service model for delivering high-quality 3D-printed, patient-specific medical devices for over two decades.”

VSP Bolus is intended for the delivery of biocompatible, 3D-printed, patient-specific boluses, which can improve patient comfort, enhance therapy modulation and lower technician time.

The solution is 3D-printed to the exact treatment plan bolus dimensions from a soft, biocompatible material that contours to the anatomy of the patient for an enhanced treatment experience.

Radiotherapy clinics across Canada and the US can now access this 3D-printed solution because of the distribution agreement with Klarity.

Klarity CEO Peter Larson said: “This collaboration aligns perfectly with Klarity’s ongoing commitment to improving the quality of care provided by our customers.

“As a North American distributor of 3D Systems’ 3D-printed biocompatible bolus products, we will be at the forefront of advancing personalised care and improving the patient experience.”

Generative AI set to transform the medical devices industry

Generative AI can improve personalized healthcare by collecting data from patients via wearable devices, which can provide continuous, real-time data that can complement traditional data sources such as imaging, patient records, and more. It can also enhance existing imaging techniques by generating high-quality images of organs using data from low-resolution images (such as ultrasounds). However, the collection and use of patient healthcare data through AI medical products could conflict with regulations around the globe.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close